tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CNTA Stock Latest News

These 3 Unknown Stocks Can Double, Say Five-Star Analysts – 12/11/2025
Market NewsThese 3 Unknown Stocks Can Double, Say Five-Star Analysts – 12/11/2025
4d ago
CLDX
CNTA
Centessa falls -8.4%
PremiumThe Fly
Centessa falls -8.4%
4d ago
CNTA
Centessa Pharmaceuticals Appoints New CEO Amid Strategic Shift
PremiumCompany Announcements
Centessa Pharmaceuticals Appoints New CEO Amid Strategic Shift
4d ago
8K
CNTA
Strategic Leadership and Orexin Program Expansion Boost Centessa Pharmaceuticals’ Growth Potential
PremiumRatings
Strategic Leadership and Orexin Program Expansion Boost Centessa Pharmaceuticals’ Growth Potential
4d ago
CNTA
Centessa CEO Saurabh Saha to step down, Mario Alberto Accardi to succeed
PremiumThe Fly
Centessa CEO Saurabh Saha to step down, Mario Alberto Accardi to succeed
4d ago
CNTA
Centessa assumed with an Outperform at Oppenheimer
PremiumThe FlyCentessa assumed with an Outperform at Oppenheimer
5d ago
CNTA
Centessa price target raised to $42 from $33 at B. Riley
Premium
The Fly
Centessa price target raised to $42 from $33 at B. Riley
14d ago
ALKS
CNTA
Centessa Pharmaceuticals Amends Sales Agreement for Flexibility
Premium
Company Announcements
Centessa Pharmaceuticals Amends Sales Agreement for Flexibility
21d ago
8K
CNTA
Centessa price target raised to $43 from $28 at Guggenheim
PremiumThe Fly
Centessa price target raised to $43 from $28 at Guggenheim
27d ago
ALKS
CNTA
Centessa Pharmaceuticals Announces Underwriting Agreement for ADS Offering
PremiumCompany Announcements
Centessa Pharmaceuticals Announces Underwriting Agreement for ADS Offering
1M ago
8K
CNTA
Centessa Pharmaceuticals: Promising Market Position with ORX750’s Superior Efficacy and Potential
PremiumRatings
Centessa Pharmaceuticals: Promising Market Position with ORX750’s Superior Efficacy and Potential
1M ago
CNTA
Morgan Stanley sees Centessa’s ORX750 as ‘best-in-class’ after competitor data
PremiumThe Fly
Morgan Stanley sees Centessa’s ORX750 as ‘best-in-class’ after competitor data
1M ago
ALKS
CNTA
Midday Fly By: AMD sees acceleration, IBM unveils quantum processor
PremiumThe FlyMidday Fly By: AMD sees acceleration, IBM unveils quantum processor
1M ago
C
T
Centessa rises 14.0%
Premium
The Fly
Centessa rises 14.0%
1M ago
CNTA
Evercore disagrees with Street reaction on Alkermes
Premium
The Fly
Evercore disagrees with Street reaction on Alkermes
1M ago
TAK
ALKS
Centessa 11.63M share Spot Secondary priced at $21.50
PremiumThe Fly
Centessa 11.63M share Spot Secondary priced at $21.50
1M ago
CNTA
Centessa announces American Depositary Shares offering, no amount given
PremiumThe Fly
Centessa announces American Depositary Shares offering, no amount given
1M ago
CNTA
Centessa Pharmaceuticals: Promising Developments in Sleep Disorder Treatments Drive Buy Rating
PremiumRatings
Centessa Pharmaceuticals: Promising Developments in Sleep Disorder Treatments Drive Buy Rating
1M ago
CNTA
Centessa Pharmaceuticals Advances OX2R Agonist Program
PremiumCompany Announcements
Centessa Pharmaceuticals Advances OX2R Agonist Program
1M ago
CNTA
RBC says Centessa data highlights ‘impressive profile’ of Alkermes’ alixorexton
PremiumThe FlyRBC says Centessa data highlights ‘impressive profile’ of Alkermes’ alixorexton
1M ago
ALKS
CNTA
Centessa narcolepsy data not superior to Alkermes, says Stifel
Premium
The Fly
Centessa narcolepsy data not superior to Alkermes, says Stifel
1M ago
ALKS
CNTA
Alkermes jumps 10% after Centessa narcolepsy data
Premium
The Fly
Alkermes jumps 10% after Centessa narcolepsy data
1M ago
ALKS
CNTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >